Overview
Current Appointments & Affiliations
Professor Emeritus in Psychiatry and Behavioral Sciences
·
2022 - Present
Psychiatry & Behavioral Sciences, Behavioral Medicine & Neurosciences,
Psychiatry & Behavioral Sciences
Faculty Network Member of the Duke Institute for Brain Sciences
·
2008 - Present
Duke Institute for Brain Sciences,
University Institutes and Centers
Recent Publications
Assessing the inter-rater reliability of the Schizophrenia Cognition Rating Scale: a non-interventional quantitative study
Journal Article Schizophrenia · December 1, 2025 Background: Cognitive impairment is a core feature of schizophrenia, profoundly impacting patients’ functional abilities. As such, evaluating cognition-related functional activity/impairment is essential for identifying effective treatments. This study pre ... Full text CitePrimary and secondary caregiver burden of cognitive impairment associated with schizophrenia: a qualitative study based on caregiver interviews
Journal Article Schizophrenia · December 1, 2025 Cognitive impairment associated with schizophrenia (CIAS) places a significant burden on patients and caregivers. This study explored the burden experienced by primary (informal) and secondary (formal) caregivers. A secondary qualitative analysis was perfo ... Full text CiteConcept confirmation of the Schizophrenia Cognition Rating Scale (SCoRS) among unpaid and professional caregivers
Journal Article Schizophrenia · December 1, 2025 Schizophrenia is a complex mental health condition characterized by a range of heterogenous symptoms. Cognitive impairment associated with schizophrenia (CIAS) interferes with individuals’ ability to manage their daily activities and has a detrimental effe ... Full text CiteRecent Grants
A phase II randomised, double-blind, placebo-controlled study to evaluate the efficacy, safety, and tolerability of orally administered BI 409306 during a 52-week treatment period as an early intervention in patients with attenuated psychosis syndrom
Clinical TrialPrincipal Investigator · Awarded by Boehringer Ingelheim Pharmaceuticals, Inc. · 2017 - 2021Auditory Perception and Emotion Recognition in Young People at Risk for Psychosis
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2016 - 2019Study to Evaulate the Kappa Opioid Receptor as a Target for the Treatment of Mood and Anxiety Spectrum Disorders by Evaluating Whether LY2456302 Engages Reward-related Neural Circuitry.
Clinical TrialCo Investigator · Awarded by National Institutes of Health · 2013 - 2017View All Grants
Education, Training & Certifications
New York University ·
1990
Ph.D.